Security key
92764N102
Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR)
CUSIP: 92764N102
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 168,432,200
- Total 13F shares
- 88,056,992
- Share change
- -936,798
- Total reported value
- $783,680,407
- Put/Call ratio
- 57%
- Price per share
- $8.90
- Number of holders
- 213
- Value change
- -$9,558,987
- Number of buys
- 106
- Number of sells
- 97
Report period
Q2 2024
Institutions
213
Top holders
10
VIR full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Vir Biotechnology, Inc. SEC filings
Vir Biotechnology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92764N102
Recent filing periods:
Top shareholders of VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD |
13F
|
Company |
9.9%
|
16,684,041
|
$169,009,335 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
9.8%
|
16,563,612
|
$167,789,388 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.3%
|
12,375,355
|
$125,362,346 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.2%
|
7,067,621
|
$71,595,001 | — | 31 Mar 2024 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
2.3%
|
3,947,065
|
$39,983,768 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2%
|
3,407,832
|
$34,521,338 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.4%
|
2,339,260
|
$23,696,710 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,949,189
|
$19,748,111 | — | 31 Mar 2024 | |
| Gates Foundation |
13F
|
Company |
0.93%
|
1,559,142
|
$15,794,108 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.81%
|
1,356,100
|
$13,737,000 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.75%
|
1,268,744
|
$12,852,377 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.67%
|
1,136,354
|
$11,511,266 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.67%
|
1,124,731
|
$11,393,525 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.6%
|
1,014,679
|
$10,278,698 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.54%
|
902,342
|
$9,140,725 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.51%
|
858,591
|
$8,697,526 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.49%
|
829,311
|
$8,400,921 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.48%
|
806,929
|
$8,174,191 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.42%
|
703,528
|
$7,126,739 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.38%
|
646,254
|
$6,546,553 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.38%
|
641,327
|
$6,496,643 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.38%
|
640,000
|
$6,483,200 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.34%
|
579,126
|
$5,866,547 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.28%
|
466,208
|
$4,722,687 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.28%
|
463,247
|
$4,692,692 | — | 31 Mar 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.27%
|
462,030
|
$4,680,364 | — | 31 Mar 2024 | |
| Empowered Funds, LLC |
13F
|
Company |
0.27%
|
458,044
|
$4,639,986 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.27%
|
448,960
|
$4,547,965 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.26%
|
439,323
|
$4,450,342 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.19%
|
322,576
|
$3,267,695 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.18%
|
310,091
|
$3,141,222 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.17%
|
285,000
|
$2,887,050 | — | 31 Mar 2024 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.16%
|
269,912
|
$2,734,209 | — | 31 Mar 2024 | |
| Capital International Investors |
13F
|
Company |
0.15%
|
258,400
|
$2,617,592 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.15%
|
251,289
|
$2,545,557 | — | 31 Mar 2024 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.14%
|
235,664
|
$2,408,486 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.14%
|
228,687
|
$2,316,575 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.12%
|
208,300
|
$2,110,079 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.11%
|
186,843
|
$1,892,720 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.11%
|
185,200
|
$1,876,076 | — | 31 Mar 2024 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.11%
|
178,659
|
$1,809,816 | — | 31 Mar 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.1%
|
172,656
|
$1,749,005 | — | 31 Mar 2024 | |
| State of Alaska, Department of Revenue |
13F
|
Company |
0.09%
|
152,447
|
$1,544,000 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.09%
|
149,268
|
$1,512,085 | — | 31 Mar 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.08%
|
142,729
|
$1,445,845 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.07%
|
124,300
|
$1,259,159 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.07%
|
109,620
|
$1,110,451 | — | 31 Mar 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.06%
|
102,900
|
$1,042,377 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.06%
|
102,894
|
$1,042,315 | — | 31 Mar 2024 | |
| DUALITY ADVISERS, LP |
13F
|
Company |
0.06%
|
101,479
|
$1,027,982 | — | 31 Mar 2024 |
Institutional Holders of Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) as of Q2 2024
As of 30 Jun 2024,
Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) was held by
213 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
88,056,992 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, BAILLIE GIFFORD & CO, ORBIMED ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Bill & Melinda Gates Foundation, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
213
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
205
Q2 2024 holders
213
Holder diff
8
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.